Skip to content
Screener

Bausch Health Companies BHC Q1 2026 earnings

Reported April 29, 2026 · After market close

Revenue$2.5BBeat by $101.7M
EPS$0.78Miss by $0.03
Revenue estimate$2.4B
EPS estimate$0.81

Next report

Oct 28, 2026 (in a month)
Revenue estimate$2.8B
EPS estimate$1.19

Financials

Q1 2026

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$2B-15.9%
Enterprise value$21.45B-5.6%
P/S0.2×-0.1×

Profitability

See full
Operating margin5.6%-10.3pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Current ratio1.3×0.0×

Segments

By segment

See full
Bausch + Lomb$1.2B+9.4%
Salix$639.0M+17.9%
International$285.0M+8.8%
Diversified$185.0M-9.8%
Solta Medical$171.0M+51.3%

FAQ

When did Bausch Health Companies report Q1 2026 earnings?
Bausch Health Companies (BHC) reported Q1 2026 earnings on April 29, 2026 after market close.
What were Bausch Health Companies's Q1 2026 revenue and EPS?
Bausch Health Companies reported revenue of $2.5B and eps of $0.78 for Q1 2026.
Did Bausch Health Companies beat estimates in Q1 2026?
Revenue beat the consensus estimate of $2.4B by $101.7M. EPS missed the consensus estimate of $0.81 by $0.03.
How did Bausch Health Companies's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.3% from $2.3B a year earlier and eps grew 32.2% from $0.59.
Where can I find Bausch Health Companies's Q1 2026 SEC filings?
You can read the 8-K earnings release (0000885590-26-000051) and the 10-Q periodic report (0000885590-26-000053) directly on SEC EDGAR. The filing index links above go to sec.gov.